Advanced Brain Health Scan
Enhanced MRI imaging for deeper neurological and brain health insights
Device · On PremiseCompany source
Company profile
About Prenuvo
Prenuvo is a preventative health screening company that combines advanced Whole Body MRI technology with comprehensive blood biomarker analysis to provide proactive health assessments. The company's flagship service captures 1.3 billion data points during a radiation-free, contrast-free scan that takes less than an hour, screening for hundreds of conditions across major organ systems. Prenuvo offers tiered membership options including Core, Comprehensive, and Executive scans, with scan times ranging from 45 to 75 minutes. Each membership includes personalized results reviews with healthcare professionals and access to enhanced imaging options such as FDA-cleared Body Composition Analysis, Advanced Brain Health Scan, and Advanced Heart Health Scan. The company's blood panels measure more than 80 biomarkers tied to inflammation, hormone levels, and metabolic health. With over 26 locations across North America, Australia, and the United Kingdom, Prenuvo has served more than 170,000 patients. The Prenuvo Medical Group includes more than 200 healthcare professionals, including radiologists, MRI technologists, preventative health physicians, and nurse practitioners who support patients throughout the entire screening process. The company's approach emphasizes establishing health baselines and tracking changes over time through annual screenings, enabling early detection and proactive health management.
Company description Prenuvo official website
Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Prenuvo?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Cancer screening
- Cardiovascular disease
- Lymphoma
- Metabolic disorders
- Multi-organ system conditions
- Neurological conditions
- Spine degeneration
Who it serves
- Direct-to-consumer patients
- Employers
- Healthcare providers
Deployment & integration
Embedded · On Premise deployment with recorded integration context.
Geographic context
MarketsAustralia · Canada · United Kingdom · United States
Company sourceOfficial website
Company milestones
Platform expansion
Expanded to more than 26 locations across multiple countries, served over 170,000 patients, launched tiered membership model with pricing starting at $1,199
Partnerships
Recorded partners
- Independent medical practitioners for referrals
- Prenuvo Medical Group (exclusively-affiliated radiology group)
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Advanced Heart Health Scan
Specialized cardiac imaging for comprehensive cardiovascular assessment
Device · On PremiseCompany source
Blood Biomarker Testing
Comprehensive blood panels measuring 80+ biomarkers for metabolic and inflammatory health
Service · On PremiseCompany source
Body Composition Analysis
FDA-cleared advanced imaging enhancement for deeper body composition insights
Software · EmbeddedCompany source
Whole Body Scan
Comprehensive MRI screening for hundreds of conditions across major organ systems in under an hour
Device · On PremiseCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Letter to the Editor: Clarifying interpretation of cancer detection utility from whole-body MRI.European radiology · Apr 1, 2026
Prevalence and Size-Based Risk Categorization of Pancreatic Cysts Among Asymptomatic Individuals With Screening MRI.JAMA network open · Mar 2, 2026
Nursing's "professional" status, loan policy, and the risks of self-generated misinformation.Nursing outlook · Jan 1, 2026
Smoking predicts brain atrophy in 10,134 healthy individuals and is potentially influenced by body mass index.NPJ dementia · Jan 1, 2025
Visceral and Subcutaneous Abdominal Fat Predict Brain Volume Loss at Midlife in 10,001 Individuals.Aging and disease · Aug 1, 2024
Exercise-Related Physical Activity Relates to Brain Volumes in 10,125 Individuals.Journal of Alzheimer's disease : JAD · Jan 1, 2024
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
Prenuvo Body CompositionK242825 · 510k · Jan 17, 2025
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Early lymphoma detection improving cure rates from 20% to 90%
Patient testimonial - Vladek
1.3 billion data points captured per Whole Body Scan
Technical capability of imaging system
Screens for hundreds of conditions across major organ systems
Whole Body Scan capability
80+ biomarkers measured
Blood panel testing
Jena
Proactive health screening for peace of mind
Patient reported 100% satisfaction and peace of mind from comprehensive screening
Latonia
Detection of previously unknown condition before symptoms appeared
Condition detected before it could worsen significantly
Vladek
Early detection of lymphoma through whole-body MRI screening
Early detection improved cure chances from 20% to 90%
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
06 · Company updates
Updates from Prenuvo
Recent articles published on Prenuvo's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Medical Imaging & Radiology
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.